NO20063057L - Nitrooksyderivater av carvedilol og andre betablokkere som antihypertensive legemidler - Google Patents
Nitrooksyderivater av carvedilol og andre betablokkere som antihypertensive legemidlerInfo
- Publication number
- NO20063057L NO20063057L NO20063057A NO20063057A NO20063057L NO 20063057 L NO20063057 L NO 20063057L NO 20063057 A NO20063057 A NO 20063057A NO 20063057 A NO20063057 A NO 20063057A NO 20063057 L NO20063057 L NO 20063057L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- blockers
- oxide derivatives
- carvedilol
- beta
- Prior art date
Links
- 239000002876 beta blocker Substances 0.000 title abstract 2
- ZWWCURLKEXEFQT-UHFFFAOYSA-N dinitrogen pentaoxide Chemical class [O-][N+](=O)O[N+]([O-])=O ZWWCURLKEXEFQT-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002220 antihypertensive agent Substances 0.000 title 1
- 229940127088 antihypertensive drug Drugs 0.000 title 1
- 229940097320 beta blocking agent Drugs 0.000 title 1
- 229960004195 carvedilol Drugs 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 229910004679 ONO2 Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Oppfinnelsen angår nitrooksyderivater av ß-adrenerge blokkere med generell formel (I) : A- (Y-ONO2) , hvor s er et helt tall lik 1 eller 2; A er valgt blant følgende ß-adrenerge blokkerrester med formel (II) hvor R1 er valgt blant formel (IIa) formel (IIb) formel (IIc) og andre rester definert i krav 1; R2 er valgt blant -CH(CH3)2, -C(CH3)3 og formel (IIIa) og formel (IIIb) Z er H eller en gruppe med evne til å binde Y, som definert i krav 1; Z1 er H eller -C(O)- med evne til å binde Y; de andre substituentene er definert i krav 1; og enantiomerer, diastereoisomerer og farmasøytisk akseptable salter av disse, farmasøytiske preparater som inneholder forbindelsene og anvendelse av dem ved behandling av hypertensjon, kardiovaskulære sykdommer, glaukom, migrene og vaskulære sykdommer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104484 | 2003-12-02 | ||
| PCT/EP2004/013683 WO2005053685A1 (en) | 2003-12-02 | 2004-12-01 | Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063057L true NO20063057L (no) | 2006-06-30 |
Family
ID=34639309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063057A NO20063057L (no) | 2003-12-02 | 2006-06-30 | Nitrooksyderivater av carvedilol og andre betablokkere som antihypertensive legemidler |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7825263B2 (no) |
| EP (1) | EP1691804B1 (no) |
| JP (1) | JP2007513114A (no) |
| KR (1) | KR20060120677A (no) |
| CN (1) | CN1886132A (no) |
| AR (1) | AR047732A1 (no) |
| AT (1) | ATE358478T1 (no) |
| AU (1) | AU2004294297A1 (no) |
| BR (1) | BRPI0416584A (no) |
| CA (1) | CA2548129A1 (no) |
| DE (1) | DE602004005748T2 (no) |
| DK (1) | DK1691804T3 (no) |
| ES (1) | ES2285549T3 (no) |
| HR (1) | HRP20070283T3 (no) |
| IL (1) | IL174959A0 (no) |
| NO (1) | NO20063057L (no) |
| PL (2) | PL380065A1 (no) |
| PT (1) | PT1691804E (no) |
| RU (1) | RU2006119528A (no) |
| SI (1) | SI1691804T1 (no) |
| WO (1) | WO2005053685A1 (no) |
| ZA (1) | ZA200604458B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE437637T1 (de) | 2001-05-02 | 2009-08-15 | Nitromed Inc | Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren |
| WO2007090733A1 (en) * | 2006-02-06 | 2007-08-16 | Nicox S.A. | Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists |
| EP1981852A1 (en) | 2006-02-06 | 2008-10-22 | NicOx S.A. | Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
| WO2008112287A1 (en) | 2007-03-12 | 2008-09-18 | Nektar Therapeutics | Oligomer-beta blocker conjugates |
| US8425972B2 (en) | 2007-05-14 | 2013-04-23 | Covidien Lp | Antimicrobial materials and coatings |
| US8062653B2 (en) * | 2009-02-18 | 2011-11-22 | Bezwada Biomedical, Llc | Controlled release of nitric oxide and drugs from functionalized macromers and oligomers |
| EP3589327A4 (en) * | 2017-03-03 | 2022-04-06 | Synovo GmbH | NOVEL ANTI-INFECTION AND ANTI-INFLAMMATORY COMPOUNDS |
| CN115246774A (zh) * | 2021-04-27 | 2022-10-28 | 南昌弘益科技有限公司 | 一类新型双羰基类阿魏酸衍生物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2805404A1 (de) * | 1978-02-09 | 1979-08-16 | Merck Patent Gmbh | 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung |
| DE3443998A1 (de) * | 1984-12-01 | 1986-06-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| DE3512627A1 (de) | 1985-04-06 | 1986-10-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel |
| ES2065291B1 (es) * | 1993-07-30 | 1995-10-01 | Prodesfarma Sa | "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente" |
| US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| IT1295694B1 (it) | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
| PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
| IT1311924B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1311923B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1314184B1 (it) * | 1999-08-12 | 2002-12-06 | Nicox Sa | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo |
| JP2004525941A (ja) * | 2001-04-02 | 2004-08-26 | スミスクライン・ビーチャム・コーポレイション | 治療方法 |
| ATE371644T1 (de) * | 2001-05-28 | 2007-09-15 | Chemtech Res Inc | Neues alkaloidderivat und dieses enthaltende pharmazeutische zusammensetzung |
| ITMI20020148A1 (it) * | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
-
2004
- 2004-12-01 PL PL380065A patent/PL380065A1/pl not_active Application Discontinuation
- 2004-12-01 CN CNA200480035459XA patent/CN1886132A/zh active Pending
- 2004-12-01 RU RU2006119528/04A patent/RU2006119528A/ru not_active Application Discontinuation
- 2004-12-01 DK DK04803434T patent/DK1691804T3/da active
- 2004-12-01 PT PT04803434T patent/PT1691804E/pt unknown
- 2004-12-01 DE DE602004005748T patent/DE602004005748T2/de active Active
- 2004-12-01 AU AU2004294297A patent/AU2004294297A1/en not_active Abandoned
- 2004-12-01 WO PCT/EP2004/013683 patent/WO2005053685A1/en active Application Filing
- 2004-12-01 JP JP2006541892A patent/JP2007513114A/ja active Pending
- 2004-12-01 EP EP04803434A patent/EP1691804B1/en active Active
- 2004-12-01 KR KR1020067010491A patent/KR20060120677A/ko not_active Application Discontinuation
- 2004-12-01 CA CA002548129A patent/CA2548129A1/en not_active Abandoned
- 2004-12-01 BR BRPI0416584-5A patent/BRPI0416584A/pt not_active IP Right Cessation
- 2004-12-01 PL PL04803434T patent/PL1691804T3/pl unknown
- 2004-12-01 US US10/577,912 patent/US7825263B2/en not_active Expired - Fee Related
- 2004-12-01 ES ES04803434T patent/ES2285549T3/es active Active
- 2004-12-01 AR ARP040104485A patent/AR047732A1/es not_active Application Discontinuation
- 2004-12-01 AT AT04803434T patent/ATE358478T1/de not_active IP Right Cessation
- 2004-12-01 SI SI200430328T patent/SI1691804T1/sl unknown
-
2006
- 2006-03-31 ZA ZA200604458A patent/ZA200604458B/xx unknown
- 2006-04-11 IL IL174959A patent/IL174959A0/en unknown
- 2006-06-30 NO NO20063057A patent/NO20063057L/no not_active Application Discontinuation
-
2007
- 2007-06-27 HR HR20070283T patent/HRP20070283T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20070072854A1 (en) | 2007-03-29 |
| DK1691804T3 (da) | 2007-07-16 |
| CN1886132A (zh) | 2006-12-27 |
| RU2006119528A (ru) | 2008-01-10 |
| WO2005053685A1 (en) | 2005-06-16 |
| EP1691804A1 (en) | 2006-08-23 |
| JP2007513114A (ja) | 2007-05-24 |
| BRPI0416584A (pt) | 2007-01-30 |
| ATE358478T1 (de) | 2007-04-15 |
| KR20060120677A (ko) | 2006-11-27 |
| HRP20070283T3 (en) | 2007-11-30 |
| DE602004005748T2 (de) | 2007-12-27 |
| SI1691804T1 (sl) | 2007-10-31 |
| ZA200604458B (en) | 2007-04-25 |
| ES2285549T3 (es) | 2007-11-16 |
| PL1691804T3 (pl) | 2007-08-31 |
| CA2548129A1 (en) | 2005-06-16 |
| AU2004294297A1 (en) | 2005-06-16 |
| PT1691804E (pt) | 2007-07-04 |
| US7825263B2 (en) | 2010-11-02 |
| IL174959A0 (en) | 2006-08-20 |
| AR047732A1 (es) | 2006-02-15 |
| PL380065A1 (pl) | 2006-12-11 |
| DE602004005748D1 (de) | 2007-05-16 |
| EP1691804B1 (en) | 2007-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063057L (no) | Nitrooksyderivater av carvedilol og andre betablokkere som antihypertensive legemidler | |
| NO20084302L (no) | 2-(syklisk amino)-pyrimidonderivater som TPK1-inhibitorer | |
| NO20052378L (no) | Pre-organiserte trisykliske integraseinhibitorforbindelser | |
| NO20070258L (no) | Benzyltriazolonforbindelser som ikke-nukleoside revers transkriptase inhibitorer | |
| CO5721006A2 (es) | Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa | |
| DK1716152T3 (da) | Kondenserade heterocykliske forbindelser og deres anvendelse som metabotrope receptorantagonister til behandling af gastrointentinde lidelser | |
| TWI262917B (en) | 2-Furancarboxylic hydrazides and pharmaceutical compositions containing the same | |
| NO20076197L (no) | Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander | |
| WO2007095174A3 (en) | Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions | |
| NO20064579L (no) | Bifenylforbindelser anvendelige som muskariniske receptorantagonister | |
| AR065421A1 (es) | Inhibidores heterociclicos de la aspartil proteasa | |
| DK1830841T3 (da) | Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1 | |
| JO2282B1 (en) | Oxazole derivatives | |
| WO2005080384A3 (en) | Benzimidazole derivative and use as aii receptor antagonist | |
| ATE401073T1 (de) | Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1 | |
| NO20073283L (no) | Nye pyridotienopyrimidinderivater | |
| NO20076060L (no) | Piperidin-4-yl-amidderivater og deres anvendelse som SST-reseptor subtype 5-antagonister | |
| NO20082747L (no) | Arylisoksazol-4-yl-imidazolderivater | |
| WO2007017728A3 (en) | Novel heterocyclic compounds | |
| NO20073271L (no) | Nye pyridotienopyrimidinderivater | |
| ATE464296T1 (de) | Selektive nichtsteroidale glucocorticoid-rezeptor-modulatoren | |
| EP1798216A4 (en) | INTERMEDIATE PRODUCT OF A 6-SUBSTITUTED 1-METHYL-1H-BENZIMIDAZOLE DERIVATIVE AND METHOD FOR THE PRODUCTION THEREOF | |
| CA2373395A1 (en) | Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors | |
| WO2008128832A1 (en) | Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome | |
| NO20062307L (no) | Spirofuropyridinarylderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |